|
| 36494209 | Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial. | J Thorac Cardiovasc Surg | 2024 |
| 37956961 | Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. | J Am Coll Cardiol | 2024 |
| 37931426 | Prospective Study of Risk Factors for Postoperative Atrial Fibrillation After Cardiac Surgery. | J Surg Res | 2024 |
| 36380569 | Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation. | Eur Heart J | 2023 |
| 37952133 | Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. | N Engl J Med | 2023 |
| 37479054 | Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials. | J Card Fail | 2023 |
| 37506747 | Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial. | Am Heart J | 2023 |
| 37969642 | Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate Cancer: A Systematic Review. | JACC CardioOncol | 2023 |
| 37461214 | Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation. | Europace | 2023 |
| 36990261 | Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores. | Am Heart J | 2023 |
| 37417248 | Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up. | Circulation | 2023 |
| 36813377 | Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week. | J Am Coll Cardiol | 2023 |
| 36583436 | Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention. | J Am Heart Assoc | 2023 |
| 36610532 | Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: AÂ Randomized Trial. | Ann Thorac Surg | 2023 |
| 36934978 | Postoperative pericardial effusion, pericardiotomy, and atrial fibrillation: An explanatory analysis of the PALACS trial. | Am Heart J | 2023 |
| 36757536 | Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study. | Am J Cardiovasc Drugs | 2023 |
| 33367487 | Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35678560 | Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. | Eur J Cardiothorac Surg | 2022 |
| 35612866 | Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. | JAMA Cardiol | 2022 |
| 35675092 | External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial. | JAMA Cardiol | 2022 |
| 35405099 | Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial. | Am Heart J | 2022 |
| 35835600 | Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials). | Am J Cardiol | 2022 |
| 35643391 | Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials. | Anaesth Crit Care Pain Med | 2022 |
| 35344405 | Equipoise in Clinical Trials: Enough Uncertainty in Whose Opinion? | Circulation | 2022 |
| 35569564 | Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model. | Am Heart J | 2022 |
| 36030390 | A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. | Circulation | 2022 |
| 36121911 | Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. | Circulation | 2022 |
| 36156131 | Predictors and associated clinical outcomes of low cardiac output syndrome following cardiac surgery: insights from the LEVO-CTS trial. | Eur Heart J Acute Cardiovasc Care | 2022 |
| 36186466 | Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events. | Front Genet | 2022 |
| 34985309 | Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. | Circulation | 2022 |
| 34936861 | Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts. | Am Heart J | 2022 |
| 35172988 | Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial. | Open Heart | 2022 |
| 35115097 | Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention. | J Am Coll Cardiol | 2022 |
| 35263653 | Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial. | Am Heart J | 2022 |
| 34358298 | Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. | Cardiovasc Res | 2022 |
| 32359794 | Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence. | J Thorac Cardiovasc Surg | 2021 |
| 33709098 | The association between coronary graft patency and clinical status in patients with coronary artery disease. | Eur Heart J | 2021 |
| 33564423 | Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial. | Clin Kidney J | 2021 |
| 33891907 | Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial. | Am Heart J | 2021 |
| 33657831 | Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. | Circ Arrhythm Electrophysiol | 2021 |
| 34873913 | Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial. | J Am Heart Assoc | 2021 |
| 34459214 | Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial. | Circulation | 2021 |
| 34627488 | Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply. | Lancet | 2021 |
| 34390530 | Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. | J Thromb Haemost | 2021 |
| 34476096 | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial. | Clin Kidney J | 2021 |
| 34297072 | Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials. | JAMA Netw Open | 2021 |
| 34097856 | Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. | Lancet | 2021 |
| 34338767 | Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. | Eur Heart J | 2021 |
| 33461308 | Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. | Circulation | 2021 |
| 33026416 | Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. | JAMA Cardiol | 2021 |